Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 105.00
+1.00 (0.96%)
At close: Mar 27, 2026
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 7.29 billion as of March 27, 2026. Its market cap has decreased by -35.95% in one year.
Market Cap
7.29B
Enterprise Value
6.17B
Revenue
593.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
105.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 7.29B, an increase of 1,451.36%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.29B | 0.15% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.56B |
| MEDINET | 8.00B |
| ADR120S | 7.94B |
| OncoTherapy Science | 7.91B |
| CellSource | 7.60B |
| PRISM BioLab Co.,LTD | 7.20B |
| Carna Biosciences | 7.14B |
| TMS Co., Ltd. | 6.60B |